Caplin Steriles has continuously invested into people and technologies to develop and file a healthy mix of simple and complex generic ANDAs. As on date, the company has filed 19 ANDAs, with 9 approvals (14 ANDA’s are filed on its own and 5 ANDA’s through partners).
Company continues to work on Sterile Long Acting Suspension and Emulsion products, along with simple solutions with a focus on shortage molecules. Company has capabilities to develop and manufacture Injectable Products in Vials, Lyophilized Vials, Pre-Mix Bags and Ophthalmic drops.
| Product Details | Owned By |
|---|---|
| Glycopyrrolate Injection, USP 0.2mg/mL in 1mL & 2mL single dose vial, 0.2mg/mL in 5mL & 20mL multi dose vial |  |
| Tranexamic acid Injection 100mg/mL in 10mL single dose vial | |
| Sodium nitroprusside Injection 25mg/mL in 2mL single dose vial | |
| Verapamil hydrochloride Injection, USP 2.5mg/mL in 2mL and 4mL vial | |
| Ropivacaine hydrochloride Injection, USP 2% (2mg/mL) in 20mL, 0.5% (5mg/mL) in 20mL, 0.5% (5mg/mL) in 30mL, 1% (10mg/mL) in 20mL single dose vials | |
| Phenylephrine hydrochloride Injection, USP 10mg/mL in 2mL single dose vial, 10mg/mL in 5mL and 10mL Pharmacy Bulk Package vials | |